Abstract:OBJECTIVE:To investigate clinicopathologic features, pathologic diagnosis, differential diagnosis and biological behavior of epitheioid myxofibrosarcoma (EMFS).METHODS:The clinical and pathological data of 10 cases were collected, and microscopic examination and immunostains were performed along with a review of the literatures.RESULTS:There were 5 males and 5 females with age ranging from 53 to 74 years, and the mean and median age was 63.6 and 62.5 years, respectively. Six cases developed in the extremities, including upper limbs (n=3) and lower limbs (n=3). Three developed in the trunk and 1 case in the mesentery of sigmoid colon. Tumor size ranged from 4.2 to 7.0 cm (mean, 5.3 cm). Most patients presented with painless masses with duration of 1 to 24 months (mean, 8 months). All 10 patients were treated by surgery, with adjunctive chemotherapy and/or radiotherapy in 4 patients and interventional therapy in 1 patient. Histologically, 8 cases were high grade and 2 were intermediate grade. Like the conventional myxofibrosarcomas, all primary tumors presented a multinodular growth pattern consisting of hypocellular myxoid and hypercellular areas. Prominent curvilinear vessels and pseudolipoblasts were observed in the hypocellular myxoid areas. Besides the spindled neoplastic cells, all tumors were characterized by a variable proportion of epithelioid cells with vesicular nuclei, prominent nucleoli and moderate to abundant eosinophilic cytoplasm. They were arranged singly or in small clusters in the myxoid areas, and in compact sheets in the solid areas. The epithelioid component comprised 30% to 90% of the tumors. In addition, areas with resemblance to undifferentiated pleomorphic sarcoma were also noted, especially in the recurrent tumors. Immunohistochemically, tumor cells showed diffuse staining of vimentin in 6 tested cases with focal expression of smooth muscle actin and epithelial membrane antigen in 1 case each. Ki-67 index ranged from 30% to 80% (mean, 58%). Follow-up data (range, 2 to 74 months; mean, 23 months) were available in 10 cases: 4 patients were alive with unresectable or recurrent disease and 6 patients were alive with no evidence of disease. Five patients experienced local recurrence and 2 cases developed metastasis. The median interval to recurrence/metastasis was 7 months (mean, 9 months).CONCLUSIONS:The presence of epithelioid cells in a myxofibrosarcomatous background portends an aggressive clinical behavior.EMFS should be differentiated from other myxoid sarcomas with epithelioid morphology.

Sclerosing Epithelioid Fibrosarcoma:A Case Report and Review of Literature

Skull Sclerosing Epithelioid Fibrosarcoma: A Case Report and Review of the Literature.

The clinicopathological spectrum of sclerosing epithelioid fibrosarcoma: report of an additional series with review of the literature

Primary Sclerosing Epithelioid Fibrosarcoma of the Kidney: A Case Report and Review of the Literature

Primary Sclerosing Epithelioid Fibrosarcoma of Chest Wall in a Patient with Breast Cancer: a Case Report.

Clinicopathologic Study of Epithelioid Sarcoma

Primary Sclerosing Epithelioid Fibrosarcoma of the Kidney: Report of Two Additional Cases with a Clinicopathological and Molecular Cytogenetic Study

Sclerosing Epithelioid Fibrosarcoma of the Lumbar Spine: a Case Report and Review of the Literature

Multiple bone metastasis of sclerosing epithelioid fibrosarcoma 12 years after initial surgery-increasing ki-67 labeling index.

Metastatic sclerosing epithelioid fibrosarcoma in an adult male from a tertiary care centre in India: a case report

A Rare Pediatric Mandibular Mass: Diagnosis, Treatment and Reconstruction: A Case Report

Sclerosing epithelioid fibrosarcoma of the pancreas: A case report

Sclerosing epithelioid fibrosarcoma of the kidney: clinicopathologic and molecular study of a rare neoplasm at a novel location

Sclerosing Epithelioid Fibrosarcoma of the Jaw: A case Report and Literature Review

Case Report: Radiological Features of Sclerosing Epithelioid Fibrosarcoma in the Right Fibula

A Group of Sclerosing Epithelioid Fibrosarcomas with Low-Level Amplified EWSR1-CREB3L1 Fusion Gene in Children.

Sclerosing Epithelioid Fibrosarcoma Harboring the EWSR1 - CREB3L1 Gene Fusion: The Importance of Molecular Classification in Pediatric Sarcomas

Malignant Perivascular Epithelioid Cell Tumour with Rhabdomyosarcomatous Differentiation of the Pelvic Cavity

Spinal Sclerosing Epithelioid Fibrosarcoma at the Cervicothoracic Junction.

[Epithelioid Myxofibrosarcoma: a Clinicopathologic Analysis of 10 Cases].

Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years